The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of a draft shared care protocol for riluzole for patients within adult services under Middlesbrough MND Care Centre; see the attached consultation document.
Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.
Please use this form to submit comments. All comments will be reviewed but please do not expect a personal response as we do not routinely reply to all comments. It is important to include any relevant evidence to back up any suggestions and please keep comments concise where possible.
- The messages sent from this form are transmitted via our hosts web server. If you have any security concerns about this process you can send your comments/feedback using your own email client to firstname.lastname@example.org.
- This consultation will run for four weeks and closes at 5pm on Thursday 25th January 2024.
|Riluzole for patients within adult services under Middlesbrough MND Care Centre
|039 NENC SCP - riluzole - v1.0 from RDTC - for consultation